e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.825 +0.275 (+6.04%)

Streaming Delayed Price Updated: 2:25 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat ↗

February 23, 2023

Cathie Wood and her ARK Invest firm bought $13 million in COIN stock as they bulk up holdings following Coinbase earnings.

Via Investor's Business Daily

$2M Bet On PayPal? Check Out These 4 Stocks Insiders Are Buying ↗

February 21, 2023

Although US stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

$6M Bet On RxSight? Check Out These 3 Stocks Insiders Are Buying ↗

February 14, 2023

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday ↗

November 18, 2022

U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Recursion Pharma Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗

September 26, 2022

Recursion Pharma stock cleared a key performance benchmark Monday, with its Relative Strength Rating upgraded to 89 from 76 the day before.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

FedEx, NCR, International Paper And Other Big Losers From Friday ↗

September 19, 2022

U.S. stocks closed lower with the Nasdaq Composite dropping over 100 points on Friday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

September 16, 2022

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗

September 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 12, 2022

Via Benzinga

Recursion Gains European Commission Orphan Drug Status For Rare Tumor Candidate ↗

July 21, 2022

Recursion (NASDAQ: RXRX) received Orphan Drug Designation for REC-4881 from the European Commission towards the potential treatment of familial adenomatous polyposis (FAP).

Via Benzinga

Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead ↗

July 06, 2022

As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys Ltd. (NASDAQ: SSYS)...

Via Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial ↗

June 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 06, 2022

Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million.

Via Benzinga

Recursion Pharmaceuticals's Return On Capital Employed Insights ↗

March 24, 2022

Recursion Pharmaceuticals (NASDAQ:RXRX) brought in sales totaling $2.53 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 36.91%, resulting...

Via Benzinga

68 Biggest Movers From Friday ↗

March 07, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 04, 2022

Gainers Atreca (NASDAQ:BCEL) stock moved upwards by 43.1% to $2.39 during Friday's regular session. As of 12:30 EST, Atreca's stock is trading at a volume of 19.1...

Via Benzinga

43 Stocks Moving In Friday's Mid-Day Session ↗

March 04, 2022

Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022 ↗

March 04, 2022

Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 03, 2022

Gainers Kiromic BioPharma (NASDAQ:KRBP) shares rose 32.5% to $1.04 during Thursday's pre-market session. The company's market cap stands at $16.0 million. DBV...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 07, 2022

Gainers Agile Therapeutics (NASDAQ:AGRX) ...

Via Benzinga

Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities ↗

December 06, 2021

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded...

Via Benzinga

Why Recursion Pharmaceuticals Stock Sank Today ↗

November 10, 2021

Investors reacted negatively to the company's Q3 update.

Via The Motley Fool

Bet On Biopharma: Data, Digitization, Discovery ↗

October 16, 2021

The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the...

Via Talk Markets

Stocks That Hit 52-Week Lows On Wednesday ↗

January 19, 2022

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...

Via Benzinga

68 Biggest Movers From Wednesday ↗

November 26, 2021

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...

Via Benzinga

Topics Initial Public Offering

76 Biggest Movers From Yesterday ↗

November 11, 2021

Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy